Compare CIX & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIX | NYXH |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.5M | 188.1M |
| IPO Year | 1998 | 2021 |
| Metric | CIX | NYXH |
|---|---|---|
| Price | $21.17 | $4.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | 11.4K | ★ 52.4K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | ★ 10.12% | N/A |
| EPS Growth | ★ 2.86 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $159,004,000.00 | $6,616,215.00 |
| Revenue This Year | N/A | $79.25 |
| Revenue Next Year | N/A | $297.08 |
| P/E Ratio | $13.48 | ★ N/A |
| Revenue Growth | 5.52 | ★ 10.96 |
| 52 Week Low | $17.89 | $4.35 |
| 52 Week High | $32.30 | $11.87 |
| Indicator | CIX | NYXH |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 45.06 |
| Support Level | $20.29 | $4.75 |
| Resistance Level | $22.05 | $5.04 |
| Average True Range (ATR) | 0.53 | 0.23 |
| MACD | -0.05 | 0.04 |
| Stochastic Oscillator | 61.22 | 54.62 |
Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.